Kevin Kesseler joins us in this segment. He is the President and CEO of AsystBio, and they have developed a program that will provide keys to help the pharmaceutical industry solve diseases. This is something you may not be able to understand, because I struggled to understand as well. But seeing the process of how it is monetized is fascinating.